Methods to assess in vitro drug release from injectable polymeric particulate systems

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Biomaterials

Background:

• Parenteral microparticulate drug delivery systems require robust in vitro release testing.
• Accurate assessment of real-time drug release at physiological temperatures (37°C) is crucial for subcutaneous and intramuscular formulations.
• Existing methodologies for evaluating drug release kinetics from these complex systems need comprehensive review.

Purpose of the Study:

• To compile and critically evaluate methods for studying real-time drug release from parenteral microparticulate systems.
• To describe the principles, advantages, and disadvantages of different in vitro release testing techniques.
• To provide guidance on selecting appropriate methods and discuss in vitro-in vivo correlation for injectable dosage forms.

Main Methods:

• Review of current literature on in vitro drug release testing for parenteral microparticles.
• Categorization of methods into sample-and-separate, flow-through cell, and dialysis techniques.
• Analysis of how experimental setup and sampling influence observed drug release profiles.

Main Results:

• Three primary categories of drug release methods were identified: sample-and-separate, flow-through cell, and dialysis.
• Each method presents unique advantages and disadvantages regarding setup, sampling, and potential interference.
• In vitro release results are significantly influenced by the chosen method and experimental conditions.

Conclusions:

• Selection of an appropriate in vitro release method is critical for accurate characterization of parenteral microparticulate systems.
• Development of standardized, user-friendly, and reproducible methods is needed for quality control and regulatory compliance.
• Further efforts are required to establish reliable in vitro-in vivo correlations for these injectable formulations.